Neuroleptic malignant syndrome
Figure 3.1: Flow chart of treatment options in patients with neuroleptic malignant syndrome (NMS). PO=per os, NG=nasogastric tube, bd=bis in die (twice per day), qds=quaque die (four times per day),…
Acute dystonia
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 2 Acute dystonia Anne Marthe Meppelink and Mark J. Edwards Introduction Movement disorders can occur as a side effect of many different pharmacological agents, including…
Serotonin syndrome
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 4 Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez Introduction Serotonin syndrome, a medical condition that gained prominent attention with the death of Libby…
Tardive dyskinesia treatment
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 7 Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan, and Theresa A. Zesiewicz Introduction Tardive syndromes (TS) are characterized by abnormal, involuntary movements, and are…
Tardive syndromes
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 6 Tardive syndromesClinical manifestations, pathophysiology, and epidemiology Daniel Tarsy and Raminder Parihar Introduction The tardive syndromes are a group of involuntary movement disorders which appear…
Neuroleptic parkinsonism
html xmlns=”http://www.w3.org/1999/xhtml” xmlns:mml=”http://www.w3.org/1998/Math/MathML” xmlns:epub=”http://www.idpf.org/2007/ops”> Chapter 5 Neuroleptic parkinsonism Joseph H. Friedman It is my contention, based on personal experience and common sense, based partly on extrapolation, not evidence-based studies, that…
